These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 13964516)

  • 1. [Aldosterone antagonists in the treatment of cardiac edema].
    JAKOBSON T
    Fin Lakaresallsk Handl; 1962; 106():183-97. PubMed ID: 13964516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apparently irreducible cardiac edema. Remarkable effect of a spirolactone].
    VIALA JJ; FATH A
    Lyon Med; 1961 May; 93():1217-20. PubMed ID: 13781098
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diuretic and saluretic action of an aldosterone antagonist (spirolactone, SC-9420) associated with an iso-indoline derivative (Hygroton) in refractory cardiac edema].
    STRATA A; PREIS H
    Boll Soc Ital Cardiol; 1962; 7():106-14. PubMed ID: 13917659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Aldostegone-antagonistic steroids as diuretics. Spironolactone in the treatment of hepatic and cardiac edemas].
    LEPPLA W; TIEFENSEE H
    Dtsch Med Wochenschr; 1961 Dec; 86():2395-402. PubMed ID: 14464199
    [No Abstract]   [Full Text] [Related]  

  • 5. [POTENTIATION OF MERCURIAL DIURETICS WITH PROGESTERONE].
    GOLINELLI G; MELLI A
    Arcisp S Anna Ferrara; 1964; 17():547-62. PubMed ID: 14197783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E
    Ann Biol Clin (Paris); 1962; 20():497-524. PubMed ID: 14483184
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spirolactones. Their use in the treatment of cardiac and cirrhotic edemas (apropos of 6 case reports)].
    JUSTIN-BESANCON L; LAROCHE C; NENNA A; ETIENNE JP; CREMER G
    Sem Hop; 1960 Dec; 36():3083-97. PubMed ID: 13791128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 9. ALDOSTERONE ANTAGONISTS IN DIURETIC THERAPY: THEIR EFFECT ON THE REFRACTORY PHASE.
    SELLER RH; SWARTZ CD; RAMIREZ-MUXO O; BREST AH; MOYER JH
    Arch Intern Med; 1964 Mar; 113():350-5. PubMed ID: 14096385
    [No Abstract]   [Full Text] [Related]  

  • 10. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CARDIAC EDEMA].
    KONONIACHENKO VA; GERASIMOVA EN
    Kardiologiia; 1964; 4():76-86. PubMed ID: 14184139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypokalemis, hypochloremia and alkalosis in the long-term treatment of edematous heart insufficiency with benzothiadiazine diuretics. III. Effects of spirolactone].
    OLESEN K; SANDOE E
    Ugeskr Laeger; 1962 Jul; 124():1037-41. PubMed ID: 14481741
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on the use of an aldosterone antagonist (aldactone) in the therapy of water retention].
    GHIRINGHELLI L; COMOLI G
    Minerva Med; 1962 Jun; 53():1760-3. PubMed ID: 13898209
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1167-73. PubMed ID: 14152375
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of aldosterone-antagonists in the treatment of congestive heart failure].
    Fügedi K
    Orv Hetil; 2005 Apr; 146(14):645-8. PubMed ID: 15889538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone antagonists in hypertension and heart failure.
    Mantero F; Lucarelli G
    Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1124-7. PubMed ID: 14152369
    [No Abstract]   [Full Text] [Related]  

  • 18. Autonomic effects of spironolactone and MR blockers in heart failure.
    Davies JI; Witham MD; Struthers AD
    Heart Fail Rev; 2005 Jan; 10(1):63-9. PubMed ID: 15947893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological bases of the utilization of aldosterone antagonists. Their clinical applications].
    VAN CAUWENBERGE H; LEFEBVRE P
    Acta Cardiol; 1962; 17():627-56. PubMed ID: 13995980
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical use of spirolactone SC-9420 "Aldactone"].
    KUCHEL O; HORKY K; DONOCIK A
    Cas Lek Cesk; 1962 Jul; 101():962-7. PubMed ID: 14460149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.